Nifty Pharma Today: Index Slips 0.23% to 26,479.55

Updated: 10 Aug 2026 • 4:18 pm

Posted by:

Nifty Pharma Today: Index Slips 0.23% to 26,479.55

Closing Bell | 10 August 2026 | Updated at 4:15 PM IST

Quick sector takeaways

Nifty Pharma ended 0.23% lower, down 62.25 points at 26,479.55 against the previous close of 26,541.80.
The index traded between 26,401.30 and 26,770.85 during the session, after opening at 26,588.25.
Sector breadth was negative: 13 stocks declined, six advanced and one was unchanged among 20 displayed stocks.
JB Chemicals & Pharmaceuticals, Ipca Laboratories and Lupin led the declines, while Gland Pharma posted the strongest gain. Watch whether the breadth improves in the next session.

Nifty Pharma today: end-of-session sector wrap

Nifty Pharma today finished the session in the red, closing at 26,479.55, a decline of 62.25 points or 0.23% from 26,541.80. The move placed the index at the top of the losing side among the configured sector indices for the day. While the headline decline was modest, the underlying stock picture showed broader pressure, with decliners outnumbering gainers by more than two to one.

The index began above its previous close at 26,588.25, moved as high as 26,770.85 and later fell to 26,401.30. Its close was 78.25 points above the day’s low and 291.30 points below the day’s high. That range captures an intraday reversal from the upper part of the session’s band towards a lower close.

For a wider daily-market perspective, readers can follow Univest Market View.

Price snapshot

The Nifty Pharma index closed at 26,479.55, compared with the previous close of 26,541.80. The net change was -62.25 points, or -0.23%. The day’s high was 26,770.85 and the low was 26,401.30, creating a 369.55-point intraday range.

The opening level of 26,588.25 was above the previous close, but the index did not retain that early position by the closing bell. The final level remained below both the opening mark and the previous close, while staying above the day’s low. These are price observations from the session, rather than signals of what may follow.

Sector ranking

Nifty Pharma was the top losing sector index among the configured indices on 10 August, with its 0.23% fall exceeding the declines recorded by Nifty FMCG, Nifty Bank and Nifty Auto. In the same configured set, Nifty Mid Select, Nifty Financial Services, Nifty Metal and Nifty IT closed higher.

This ranking highlights that the pharma index was relatively weaker on the day within that group. The difference was not only in the closing percentage change: the sector’s internal breadth also leaned negative, providing useful context for the index-level decline.

Constituent breadth

Of the 20 displayed Nifty Pharma stocks, 13 closed lower, six closed higher and one was unchanged. The advance-decline ratio stood at 0.46, meaning there were 0.46 advancing stocks for every declining stock. The breadth profile therefore aligned with the index’s negative close.

Positive moves in selected stocks limited the extent of the index fall, but they did not offset the wider count of declining names. Gland Pharma, Laurus Labs, Ajanta Pharma, Zydus Lifesciences, Divi’s Laboratories and Cipla were among the gainers. Torrent Pharmaceuticals was unchanged at 4,924.00.

Heavyweights versus broader participation

The supplied heavyweight group presented a mixed picture. Sun Pharmaceutical Industries eased 0.03% to 1,944.40, while Divi’s Laboratories added 0.30% to 8,300.00. Cipla rose 0.27% to 1,467.70, Torrent Pharmaceuticals was unchanged, and Dr. Reddy’s Laboratories declined 1.13% to 1,158.80.

The supplied most-active stock list contains the same five names, underlining the relevance of their closing moves to the day’s sector reading. However, broader participation remained softer, as the 13-to-six decline-to-advance count showed. The mixed heavyweight performance and weaker breadth together describe a sector that was not uniformly weak, but closed under net pressure.

Key Nifty Pharma stocks

Stock	Move	Why it matters
JB Chemicals & Pharmaceuticals	-3.87% to 2,408.90	It was the largest percentage decliner in the displayed sector list.
Ipca Laboratories	-2.88% to 1,685.80	It was among the day’s sharpest declines.
Lupin	-2.69% to 2,300.00	Its decline placed it among the leading negative movers.
Gland Pharma	+2.55% to 2,667.30	It was the strongest percentage gainer in the sector.
Dr. Reddy’s Laboratories	-1.13% to 1,158.80	It was lower within the supplied heavyweight group.

Biggest positive movers

Gland Pharma led the gainers with a 2.55% rise to 2,667.30. The stock traded between 2,610.10 and 2,685.00, finishing close to its intraday high. Laurus Labs gained 0.53% to 1,854.00, Ajanta Pharma advanced 0.49% to 3,506.20, and Zydus Lifesciences added 0.43% to 1,119.00.

Divi’s Laboratories also closed higher, up 0.30% at 8,300.00. These advances offered positive pockets within the sector, even as the index and overall breadth closed negative.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to 2,408.90 after trading between 2,380.00 and 2,525.50. Ipca Laboratories declined 2.88% to 1,685.80, while Lupin dropped 2.69% to 2,300.00. Granules India lost 2.14% to 855.15 and Glenmark Pharmaceuticals declined 1.22% to 2,251.30.

Glenmark ended at its day low of 2,251.30, while the other leading decliners remained above their respective intraday lows at the close. This describes where they finished within their daily ranges and does not establish a reason for the moves.

Stocks to watch next session

Market participants may track JB Chemicals & Pharmaceuticals, Ipca Laboratories, Lupin, Gland Pharma, Divi’s Laboratories and Sun Pharmaceutical Industries in the next session. These names combined the largest percentage moves with representation in the supplied heavyweight group.

For the decliners, attention may remain on whether their next-session moves stay negative or stabilise. For Gland Pharma and Divi’s Laboratories, the focus may be on whether their positive closes are sustained. Sun Pharmaceutical Industries, which ended nearly unchanged, may also be relevant as a closely watched heavyweight within the sector.

The constructive case

The constructive evidence from the session was clear but selective. Six stocks advanced despite the index closing lower, led by Gland Pharma’s 2.55% gain. Divi’s Laboratories and Cipla also closed higher, while Torrent Pharmaceuticals ended unchanged. The index itself closed above its intraday low, indicating that it did not finish at the weakest point of the day.

The sector’s opening level was above the previous close, and the index reached 26,770.85 during the session. Together, these observations show that positive price levels were present during the day, even though they were not retained at the close.

The cautious case

The cautious evidence was the negative close, the 0.23% index decline and the broader imbalance in breadth. Thirteen of 20 displayed stocks fell, compared with six gainers. The largest stock-level percentage moves were also concentrated on the negative side, with JB Chemicals & Pharmaceuticals, Ipca Laboratories, Lupin and Granules India all declining by more than 2%.

The index opened higher but closed below its opening level and below the previous close. It also ended substantially below the day’s high. These closing characteristics keep the focus on whether selling pressure remains broad or whether the balance between gainers and losers improves.

Univest Insights

Nifty Pharma today offered a measured index-level decline alongside distinctly negative breadth. The 0.23% fall was relatively contained, yet the 13 decliners showed that the softness extended across a larger share of the displayed sector universe.

The sector was not one-directional. Gland Pharma’s 2.55% gain stood out, while Laurus Labs, Ajanta Pharma, Zydus Lifesciences, Divi’s Laboratories and Cipla also ended higher. This separation between individual winners and the overall index decline is important when reading the closing session.

Heavyweight moves were mixed rather than uniformly negative. Divi’s Laboratories and Cipla gained, Sun Pharmaceutical Industries was nearly flat, and Dr. Reddy’s Laboratories was lower. That combination coincided with an index close above the day low but below the opening level.

For traders and investors, the key signal to watch is…

Published on 10 August 2026 at 4:18 PM IST

Frequently asked questions

What was Nifty Pharma’s closing level today?

Nifty Pharma closed at 26,479.55 on 10 August 2026.

How much did Nifty Pharma fall today?

The index declined by 62.25 points, or 0.23%, from its previous close of 26,541.80.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,770.85 and a day low of 26,401.30.

How was Nifty Pharma’s market breadth?

Among 20 displayed stocks, 13 declined, six advanced and one was unchanged.

Which stock gained the most in Nifty Pharma today?

Gland Pharma was the top gainer, rising 2.55% to 2,667.30.

Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the top loser, declining 3.87% to 2,408.90.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.